
Reckitt Benckiser Group PLC
Dettol, Lysol, Finish, Harpic, Air Wick, Vanish
Reckitt generated £14.2 billion in net revenue in FY2025 with 5.0% like-for-like growth, driven by its 11 Powerbrands that dominate the global hygiene and home care landscape. The company's product portfolio is uniquely positioned at the intersection of household chemicals and public health - brands like Lysol and Dettol have achieved medical-grade brand equity in the post-pandemic era. In a landmark July 2025 transaction, Reckitt sold its Essential Home portfolio to Advent International for $4.8 billion while retaining 30% equity, generating approximately $2.2 billion in special dividends for shareholders.
Strengths:
• Medical-grade brand equity in disinfectants - Lysol and Dettol trusted by hospitals and households equally
• 30 million products sold daily with unrivalled penetration in emerging market pharmacy and grocery channels
• Aggressive portfolio optimization (Essential Home divestiture) freeing capital for high-margin hygiene reinvestment
• R&D pipeline focused on antimicrobial resistance solutions, positioning for regulatory tailwinds
• Strong pricing power - consumers rarely trade down from trusted disinfectant brands during health crises
Weaknesses:
• Post-pandemic demand normalization for disinfectant products creates volume headwinds
• Essential Home divestiture reduces portfolio diversification, increasing concentration risk in hygiene/health
• Infant formula business (Enfamil) exposed to litigation and regulatory uncertainty in US marketRead More ▼Show Less ▲
Strengths:
• Medical-grade brand equity in disinfectants - Lysol and Dettol trusted by hospitals and households equally
• 30 million products sold daily with unrivalled penetration in emerging market pharmacy and grocery channels
• Aggressive portfolio optimization (Essential Home divestiture) freeing capital for high-margin hygiene reinvestment
• R&D pipeline focused on antimicrobial resistance solutions, positioning for regulatory tailwinds
• Strong pricing power - consumers rarely trade down from trusted disinfectant brands during health crises
Weaknesses:
• Post-pandemic demand normalization for disinfectant products creates volume headwinds
• Essential Home divestiture reduces portfolio diversification, increasing concentration risk in hygiene/health
• Infant formula business (Enfamil) exposed to litigation and regulatory uncertainty in US market
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Slough, Berkshire, United Kingdom
Founded
1999
Employees
36,000
Factories
Manufacturing across 80+ countries
Listing
LSE: RKT
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website LSE: RKT , Reckitt Annual Report
London Stock Exchange — Reckitt (RKT)
Fortune Business Insights — Household Cleaning Products Market
